Showing results (191-200 of 302) with videos related to

Sort By:
Pageof 31
Transplantation and Cellular Therapy|August 26, 2024
Tocilizumab Prophylaxis Following Axicabtagene Ciloleucel in Relapsed or Refractory Large B-Cell LymphomaFrederick L Locke, Sattva S Neelapu, Nancy L Bartlett, et al.
Blood|July 31, 2013
Clinical characteristics and outcomes of therapy-related chronic myelomonocytic leukemiaKoichi Takahashi, Naveen Pemmaraju, Paolo Strati, et al.
Leukemia & Lymphoma|August 9, 2021
Preclinical and phase I studies of KA2237, a selective and potent inhibitor of PI3K β/δ in relapsed refractory B cell lymphomaLoretta J Nastoupil, Sattva S Neelapu, Richard Eric Davis, et al.
Frontiers in Oncology|November 10, 2022
A multicenter study of ICU resource utilization in pediatric, adolescent and young adult patients post CAR-T therapyDristhi Ragoonanan, Saleh Bhar, Gopi Mohan, et al.
Blood Advances|August 14, 2019
A pilot study of pembrolizumab in smoldering myeloma: report of the clinical, immune, and genomic analysisElisabet E Manasanch, Guangchun Han, Rohit Mathur, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 29, 2013
Nonstereotyped lymphoma B cell receptors recognize vimentin as a shared autoantigenSoung-Chul Cha, Hong Qin, Shibichakravarthy Kannan, et al.
American Journal of Hematology|November 2, 2012
FLT3 mutations in myelodysplastic syndrome and chronic myelomonocytic leukemiaNaval Daver, Paolo Strati, Elias Jabbour, et al.
Nature Reviews. Clinical Oncology|September 20, 2017
Chimeric antigen receptor T-cell therapy - assessment and management of toxicitiesSattva S Neelapu, Sudhakar Tummala, Partow Kebriaei, et al.
Pageof 31